Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patient management system by Intel-GE JV gets US nod

This article was originally published in Clinica

Executive Summary

Intel Health Guide Express, a patient care management system developed by Intel-GE Care Innovations, has received 510(k) clearance from the US FDA. Intel-GE Care Innovations a joint venture between GE and Intel which became operational in January (www.clinica.co.uk, 5 January 2011), intends to start selling the system in the US in the second quarter of 2011. At the patient's end, it runs on standard consumer PCs or the Intel Health Guide PHS6000; the physician uses the Intel Health Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage chronic care. The in-home patient device can connect to devices including blood pressure monitors, glucose meters, pulse oximeters, peak flow meters and weight scales.

You may also be interested in...



Normality Reasserts Itself For Biotech IPOs

The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.

MRM Health Pulls A Pouchitis Hit Out Of The Bag

The mid-stage success is encouraging, but taking on Takeda won’t be easy.

Novartis Draws Out Its APPLAUSE

Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel